Molecular basis of epithelial thyroid tumorigenesis;Bases moleculaires de la tumorigenese epitheliale thyroidienne

Comptes Rendus de l'Academie des Sciences - Serie III

Volumn 323, Issue 6, 2000, Pages 519-528

  Suarez, Horacio Guillermo ^a  

^a Laboratory of Viral Oncology   (France)

Author keywords

Genetic alterations; Thyroid; Tumorigenic process

Indexed keywords

CYCLIC AMP; TYROSINE KINASE RECEPTOR;

CARCINOGENESIS; EPITHELIUM TUMOR; ONCOGENE; ONCOGENE RAS; ONCOGENE RET; RADIATION CARCINOGENESIS; REVIEW; THYROID TUMOR; TUMOR SUPPRESSOR GENE;

EID: 0033909536     PISSN: 07644469     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0764-4469(00)00170-0     Document Type: Review

References (43)

1. Suárez H.G. Genetic alterations in epithelial human thyroid tumours. Clin. Endocrinol. 48:1998;531-546.
2. Russo D., Arturi F., Schlumberger M., Caillou B., Monier R., Filetti S., Suárez H.G. Activating mutations of the TSH receptor in differentiated thyroid carcinomas. Oncogene. 11:1995;1907-1911.
3. Russo D., Arturi F., Wicker R., Chazenbalk M., Schlumberger M., Du Villard J.A., Caillou B., Monier R., Rapoport B., Filetti S., Suárez H.G. Genetic alterations in thyroid hyperfunctioning adenomas. J. Clin. Endocrinol. Metab. 80:1995;1347-1351.
4. Russo D., Arturi F., Suárez H.G., Schlumberger M., Du Villard J.A., Crocetti V., Filetti S. Thyrotropin receptor gene alterations in thyroid hyperfunctioning adenomas. J. Clin. Endocrinol. Metab. 81:1996;1548-1551.
5. Lemoine N.R., Mayall E.S., Wyllie F.S., Farr C.J., Hughes D., Padura R.A., Thurston V., Williams E.D., Wynford-Thomas D. Activated ras oncogenes in human thyroid cancers. Cancer Res. 48:1988;4459-4463.
6. Lemoine N.R., Mayall E.S., Wyllie F.S., Williams E.D., Goyns M., Stringer B., Wynford-Thomas D. High frequence of ras oncogene activation in all stages of human thyroid tumorigenesis. Oncogene. 4:1989;159-164.
7. Suárez H.G., Du Villard J.A., Caillou B., Schlumberger M., Tubiana M., Parmentier C., Monier R. Detection of activated ras oncogenes in human thyroid carcinomas. Oncogene. 2:1988;403-406.
8. Suárez H.G., Du Villard J.A., Severino M., Caillou B., Schlumberger M., Tubiana M., Parmentier C., Monier R. Presence of mutations in all three ras genes in human thyroid tumors. Oncogene. 5:1990;565-570.
9. Lyons J., Landis C.A., Harsh G., Vallar L., Grunewald K., Feichtinger H., Duh Q.Y., Clark O.H., Kawasaki E., Bourne H.R., McCormick F. Two G protein oncogenes in human endocrine tumors. Science. 249:1990;655-659.
10. Suárez H.G., Du Villard J.A., Caillou B., Schlumberger M., Parmentier C., Monier R. Gsp mutations in human thyroid tumors. Oncogene. 6:1991;677-679.
11. Yashimoto K., Iwahana H., Fukuda A., Sano T., Saito G., Itakura M. Role of p53 mutations in endocrine tumorigenesis: mutations detection by polymerase chain reaction-single strand conformation polymorphism. Cancer Res. 52:1992;5061-5064.
12. Bongarzone I., Pierotti M., Monzini N., Mondellini P., Manenti G., Donghi R., Pilotti S., Grieco M., Santoro M., Fusco A., Vecchio G., Della-Porta G. High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma. Oncogene. 4:1989;1457-1462.
13. Bounacer A., Wicker R., Caillou B., Cailleux A.F., Sarasin A., Schlumberger M., Suárez H.G. High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation. Oncogene. 15:1997;1263-1273.
14. Fusco A., Grieco M., Santoro M., Berlingieri M.T., Di Fiore P.P., Pilotti S., Pierotti M.A., Della-Porta G., Vecchio G. A new oncogene in human papillary thyroid carcinomas and their lymph-nodal metastases. Nature. 328:1987;170-172.
15. Grieco M., Santoro M., Berlingieri M.T., Melillo R.M., Donghi R., Bongarzone I., Pierotti M.A., Della-Porta G., Fusco A., Vecchio G. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell. 60:1990;557-563.
16. Santoro M., Carlomagno F., Hay I.D., Herrmann M.A., Grieco M., Melillo R., Pierotti M.A., Bongarzone I., Della-Porta G., Berger N., Paulin C., Fabien N., Vecchio G., Jenkins R.B., Fusco A. Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype. J. Clin. Invest. 89:1992;1517-1522.
17. Di Renzo M.F., Olivero M., Ferro S., Prat M., Bongarzone I., Pilotti S., Belfiore A., Costantino A., Vigneri R., Pierotti M.A., Comoglio P.M. Overexpression of the c-met/HGF receptor gene in human thyroid carcinomas. Oncogene. 7:1992;2549-2553.
18. Ivan M., Bond J.A., Prat M., Comoglio P.M., Wynford-Thomas D. Activated ras and ret oncogenes induce over-expression of c-met (hepatocyte growth factor receptor) in human thyroid epithelial cells. Oncogene. 14:1997;2417-2423.
19. Shi Y., Schmidt H., Juhasz F., Stensky V., Robb D., Farid N.R. High rates of ras codon 61 mutations in thyroid tumors in a iodine-deficient area. Cancer Res. 51:1991;2690-2693.
20. Wright P., Williams E.D., Lemoine N.R., Wynford-Thomas D. Radiation associated and 'spontaneous' human thyroid carcinomas show different pattern of ras oncogene mutation. Oncogene. 6:1991;471-473.
21. Namba H., Rubin S., Fagin J.A. Point mutations of ras oncogenes are an early event in thyroid tumorigenesis. Mol. Endocrinol. 4:1990;1474-1479.
22. Karga H., Lee J.K., Vickery A.L., Thor A., Gaz R.D., Jameson J.L. Ras oncogene mutations in benign and malignant thyroid neoplasms. J. Clin. Endocrinol. Metab. 73:1991;832-836.
23. Saïd S., Schlumberger M., Suárez H.G. Oncogenes in human epithelial thyroid tumorigenesis. J. Endocrinol. Inv. 6:1994;53-56.
24. Challeton C., Bounacer A., Du Villard J.A., Caillou B., De Vathaire F., Monier R., Schlumberger M., Suárez H.G. Pattern of ras and gsp oncogene mutations in radiation-associated human thyroid tumors. Oncogene. 11:1995;601-603.
25. Nikiforov Y.E., Nikiforova M.N., Gnepp D.R., Fagin J.A. Prevalence of mutations of ras and p53 in benign and malignant thyroid tumors from children exposed to radiation after Chernobyl nuclear accident. Oncogene. 13:1996;687-693.
26. Wynford-Thomas D. Molecular basis of epithelial tumorigenesis: the thyroid model. Crit. Rev. Oncog. 4:1993;1-23.
27. Du Villard J.A., Schlumberger M., Wicker R., Caillou B., Rochefort P., Feunteun J., Monier R., Parmentier C., Suárez H.G. Role of ras and gsp oncogenes in human epithelial thyroid tumorigenesis. J. Endocrinol. Inv. 18:1995;124-126.
28. O'Sullivan C.O., Barton C.M., Staddon S.L., Brown C.L., Lemoine N.R. Activating point mutations of the gsp oncogene in human thyroid adenomas. Mol. Carcinog. 4:1991;345-349.
29. Parma J., Duprez L., Van Sande J., Cochaux P., Gervy C., Mockel J., Dumont J., Vassart G. Somatic mutations in the tyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature. 365:1993;649-651.
30. Van Sande J., Parma J., Tonacchera M., Swillems S., Dumont J., Vassart G. Somatic and germline mutations of the TSH receptor gene in thyroid diseases. J. Clin. Endocrinol. Metab. 80:1995;2577-2585.
31. Michiels F., Caillou B., Talbot M., Dessarps-Freicher F., Maunoury M.T., Schlumberger M., Merckens L., Monier R., Feunteun J. Oncogenic potential of guanine nucleotide stimulatory factor alpha subunit in thyroid glands of transgenic mice. Proc. Nat. Acad. Sci. USA. 91:1994;10488-10492.
32. Wicker R., Suárez H.G. Le facteur de croissance des hépatocytes HGF-SF et son récepteur c-Met: Fonctions biologiques et activation oncogénique. Médecine/Sciences. 3:(12):1996;313-322.
33. Sarasin A., Bounacer A., Lepage F., Schlumberger M., Suárez H.G. Mechanisms of mutagenesis in mammalian cells: application to human thyroid tumors. C. R. Acad. Sci. 322:1999;143-149.
34. Bongarzone I., Monzini N., Borrello M.G., Carcano C., Ferraresi G., Arighi E., Mondellini P., Della-Porta G., Pierotti M.A. Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RIα of cyclic AMP-dependent protein kinase A. Mol. Cell. Biol. 13:1993;358-366.
35. Santoro M., Dathan N., Berlingieri M.T., Bongarzone I., Paulin C., Grieco M., Pierotti M.A., Vecchio G., Fusco A. Molecular characterization of RET/PTC3; a novel rearranged version of the RET proto-oncogene in human thyroid papillary carcinoma. Oncogene. 9:1994;509-516.
36. Fugazzola L., Pierotti M.A., Vigano E., Pacini F., Vorontsova T.V., Bongarzone I. Molecular and biochemical analysis of RET/PTC4 a novel oncogenic rearrangement between RET and ELE1 genes, in a post-Chernobyl papillary thyroid cancer. Oncogene. 13:1996;1093-1097.
37. Klugbauer S., Lengfelder E., Demidchik E.P., Rabes H.M. A new form of RET rearrangement in thyroid carcinomas of children after the Chernobyl accident. Oncogene. 13:1996;1099-1102.
38. TPC/PTC transcripts in thyroid adenomas and adenomatous goiter by an RT-PCR method. Oncogene. 6:1991;1667-1672.
39. Fugazzola L., Pilotti S., Pinchera A., Vorontsova T.V., Mondellini P., Bongarzone I., Greco A., Astakhova L., Butti M.G., Demidchik E.P., Pacini F., Pierotti M.A. Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident. Cancer Res. 55:1995;5617-5620.
40. Klugbauer S., Lengfelder E., Demidchik E.P., Rabes H.M. High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident. Oncogene. 11:1995;2459-2467.
41. Nikiforov Y.E., Rowland J.M., Bove K.E., Monforte-Muñoz H., Fagin J. Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Res. 57:1997;1690-1694.
42. Bongarzone I., Fugazzola L., Vigneri P., Mariani L., Mondellini P., Pacini F., Basolo F., Pinchera A., Pilotti S., Pierotti M.A. Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma. J. Clin. Endocrinol. Metab. 81:1996;2006-2009.
43. Fogelfeld L., Bauer T.K., Schneider A.B., Swartz J.E., Zitman R. p53 gene mutations in radiation-induced thyroid cancer. J. Clin. Endocrinol. Metab. 81:1996;3039-3044.